UNI-BIO GROUP 00690Hong Kong Stock Exchange

0.0700.00%( +0.000 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
UNI-BIO GROUP (00690) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2001-11-12
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG9198H1406

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)529.48M69/112
Net Profit (Last FY)84.29M46/125
ROE (Last FY)22.58%8/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
联康生物科技集团有限公司 Executive Director
梁国龙 Executive Director
陈大伟 Executive Director
赵志刚 Executive Director
闻亚磊 Executive Director
邱国荣 Non-Executive Director
张清 Non-Executive Director
周启明 Independent Non-Executive Director
任启民 Independent Non-Executive Director
马青山 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-03-27.

About this page

This page shows UNI-BIO GROUP (00690) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.